2020-03-30 / Last updated : 2020-05-08 HO News186 dose-response curves added Our GPCR catalog is now enriched with 186 dose-response curves for all sorts of human
2020-03-16 / Last updated : 2020-03-16 HO NewsInterview with Tanso Biosciences CEO by NIKKEI Biotech At the interview by NIKKEI Biotech, CEO Hideaki Ogasawara talks about Tanso Biosciences' proprietary GPCR func […]
2020-03-10 / Last updated : 2020-03-10 HO NewsDistributor agreement with Cosmo Bio Tanso Biosciences, Inc. has entered into a distributor agreement with Cosmo Bio Co., Ltd to provide contract a […]
2020-02-03 / Last updated : 2020-02-20 HO NewsCEO to talk at METI's pitch event on Feb. 28 Update: Feb 20. The event has been canceled due to the COVID-19 outbreak. CEO H. Ogasawara will talk about Tan […]
2019-11-01 / Last updated : 2019-12-06 HO NewsInterview with CEO published online An interview with CEO Hideaki Ogasawara has been published on the website of FoundX, an incubator run by The U […]
2019-09-13 / Last updated : 2019-09-14 HO NewsAnother grant awarded We have won a grant from Tokyo Metropolitan Government.
2019-09-03 / Last updated : 2019-09-04 HO NewsGrant Awarded Tanso Biosicences has been awarded a startup grant of nearly US$30,000 from Tokyo Metropolitan Small and Mediu […]
2019-07-28 / Last updated : 2019-11-24 HO NewsBioJapan 2019 Tanso Bioscience will be present at BioJapan 2019 in Yokohama from October 9th, Wednesday to October 11th, Fri […]
2018-12-20 / Last updated : 2019-11-19 HO NewsPatent license agreement The University of Tokyo has granted Tanso Biosciences, Inc. an exclusive license to the patent-pending technol […]
